A. Sevinç
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
- Oncology 8
- HER2/EGFR in Cancer Research 2
- Cancer Diagnosis and Treatment 2
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Yusuf Türköz (1 shared paper)Selim Doğanay (1 shared paper)H. Er (1 shared paper)Cem Evereklioğlu (1 shared paper)Nihayet Mehmet (1 shared paper)C. Camcı (3 shared papers)Nihayet Bayraktar (1 shared paper)Hülya Türk (1 shared paper)
- Journals
- Journal of Chemotherapy (2 papers)Annals of Oncology (1 paper)Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Japanese Journal of Clinical Oncology (1 paper)
- Partner nations
- TürkiyeTaiwanSouth Korea
In The Last Decade
A. Sevinç
21 papers receiving 485 citations
Peers
Comparison fields: 5 of 85
- Ophthalmology 143
- Clinical Biochemistry 79
- Endocrinology, Diabetes and Metabolism 96
- Small Animals 36
- Neurology 33
Countries citing papers authored by A. Sevinç
This map shows the geographic impact of A. Sevinç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sevinç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sevinç more than expected).
Fields of papers citing papers by A. Sevinç
This network shows the impact of papers produced by A. Sevinç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sevinç. The network helps show where A. Sevinç may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Sevinç, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 212 | |
| 2 | 2002 | 107 | |
| 3 | 2002 | 25 | |
| 4 | 2000 | 24 | |
| 5 | Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites. | 2000 | 19 |
| 6 | 2004 | 18 | |
| 7 | 2000 | 16 | |
| 8 | 2002 | 16 | |
| 9 | 2005 | 15 | |
| 10 | 2003 | 13 | |
| 11 | The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. | 2002 | 12 |
| 12 | 2007 | 10 | |
| 13 | Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure. | 2011 | 8 |
| 14 | 2001 | 6 | |
| 15 | 2002 | 6 | |
| 16 | 2011 | 3 | |
| 17 | 2012 | 2 | |
| 18 | Gluten-free diet improves iron-deficiency anaemia in patients with coeliac disease. | 2000 | 2 |
| 19 | 2006 | 1 | |
| 20 | 2014 | 1 |
About A. Sevinç
A. Sevinç is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 517 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (3 papers), Hematological disorders and diagnostics (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Diagnosis and Treatment (2 papers), Retinal and Optic Conditions (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Abdominal Trauma and Injuries (1 paper). The work is most often cited by research in Ophthalmology (143 citations), Clinical Biochemistry (79 citations), Endocrinology, Diabetes and Metabolism (96 citations), Small Animals (36 citations) and Neurology (33 citations). A. Sevinç has collaborated with scholars based in Türkiye, Taiwan and South Korea. Frequent co-authors include Yusuf Türköz, Selim Doğanay, H. Er, Cem Evereklioğlu, Nihayet Mehmet, C. Camcı, Nihayet Bayraktar, Hülya Türk, Ramazan Sarı and Ismet Aydogdu. Their work appears in journals such as Journal of Chemotherapy, Annals of Oncology, Journal of Clinical Oncology, Cancer Research and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.